Related Experiment Video
Updated: Sep 29, 2025

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Role of Chemerin/ChemR23 axis as an emerging therapeutic perspective on obesity-related vascular dysfunction
Yingying Xie1,2,3,4, Ling Liu5,6,7,8
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Abstract:
Sufficient epidemiological investigations demonstrate that there is a close correlation between obesity and vascular dysfunction. Nevertheless, specific mechanisms underlying this link remain currently unclear. Given the crucial and decisive role of vascular dysfunction in multitudinous diseases, various hypotheses had been proposed and numerous experiments were being carried out. One recognized view is that increased adipokine secretion following the expanded mass of white adipose tissue due to obesity contributes to the regulation of vascular function. Chemerin, as a neo-adipokine, whose systemic level is elevated in obesity, is believed as a regulator of adipogenesis, inflammation, and vascular dysfunction via binding its cell surface receptor, chemR23. Hence, this review aims to focus on the up-to-date proof on chemerin/chemR23 axis-relevant signaling pathways, emphasize the multifarious impacts of chemerin/chemR23 axis on vascular function regulation, raise certain unsettled questions to inspire further investigations, and explore the therapeutic possibilities targeting chemerin/chemR23.
Insights
Obesity is linked to vascular dysfunction, with chemerin (an adipokine) and its receptor chemR23 playing key roles. This review explores their impact on blood vessel health and potential therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Metabolic Disease Research
- Adipokine Signaling
Background:
- Epidemiological studies confirm a strong association between obesity and vascular dysfunction.
- The precise molecular mechanisms linking obesity to impaired vascular function are not fully understood.
- Adipokines secreted by expanded white adipose tissue in obesity are implicated in regulating vascular health.
Purpose of the Study:
- To review current evidence on the chemerin/chemR23 signaling axis.
- To elucidate the role of chemerin/chemR23 in regulating vascular function.
- To identify therapeutic strategies targeting the chemerin/chemR23 pathway.
Main Methods:
- Literature review of studies investigating chemerin and chemR23.
- Analysis of signaling pathways influenced by chemerin/chemR23.
- Synthesis of data on the impact of chemerin/chemR23 on vascular regulation.
Main Results:
- Chemerin, a neo-adipokine, is elevated in obesity and binds to its receptor, chemR23.
- The chemerin/chemR23 axis influences adipogenesis, inflammation, and vascular dysfunction.
- Evidence suggests chemerin/chemR23 signaling pathways are critical in vascular health.
Conclusions:
- The chemerin/chemR23 axis is a significant mediator between obesity and vascular dysfunction.
- Targeting the chemerin/chemR23 pathway presents potential therapeutic avenues for obesity-related vascular diseases.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of Angiogenesis and Blood Supply
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

